Loading...

GenSight Biologics S.A.

GSGTFPNK
Healthcare
Biotechnology
$0.24
$0.00(0.00%)

GenSight Biologics S.A. (GSGTF) Stock Overview

Explore GenSight Biologics S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 70.2/100

Key Financials

Market Cap37M
P/E Ratio-0.85
EPS (TTM)$-0.38
ROE0.78%
Fundamental Analysis

AI Price Forecasts

1 Week$0.24
1 Month$0.27
3 Months$0.00
1 Year Target$0.11

GSGTF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GenSight Biologics S.A. (GSGTF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.85 and a market capitalization of 37M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;